XORTX Debt Ratio from 2010 to 2024

XRTX Stock

USD 1.27 0.06 4.96%

XORTX Therapeutics Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.05 in 2024. During the period from 2010 to 2024, XORTX Therapeutics Debt Ratio regression line of annual values had r-squared of 0.73 and arithmetic mean of 0.26. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.0537

Current Value

0.051

Quarterly Volatility

0.20409061

Credit Downgrade

Yuan Drop

Covid

Check XORTX Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XORTX Therapeutics' main balance sheet or income statement drivers, such as Selling General Administrative of 1 M, Other Operating Expenses of 2.4 M or Total Operating Expenses of 2.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.89. XORTX financial statements analysis is a perfect complement when working with XORTX Therapeutics Valuation or Volatility modules.

Check out the analysis of XORTX Therapeutics Correlation against competitors.

For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Latest XORTX Therapeutics' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of XORTX Therapeutics over the last few years. It is XORTX Therapeutics' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in XORTX Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

XORTX Debt Ratio Regression Statistics

	Arithmetic Mean	0.26
	Geometric Mean	0.15
	Coefficient Of Variation	79.34
	Mean Deviation	0.20
	Median	0.44
	Standard Deviation	0.20
	Sample Variance	0.04
	Range	0.4224
	R-Value	(0.86)
	Mean Square Error	0.01
	R-Squared	0.73
	Significance	0.000047
	Slope	(0.04)
	Total Sum of Squares	0.58

XORTX Debt Ratio History

	2024	0.051
	2023	0.0537
	2019	0.0467
	2018	0.0342
	2017	0.46

Other Fundumenentals of XORTX Therapeutics

Cash Flow To Debt Ratio

XORTX Therapeutics Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Net Tangible Assets	Long Term Debt	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock	Current Deferred Revenue
Total Assets		0.98	-0.99	-0.58	0.53	0.76	0.89	1.0	-0.43	-0.74	0.91	0.56	-0.15	0.97	-0.62	1.0	0.84	0.73	0.92	-0.15
Total Stockholder Equity	0.98		-0.98	-0.55	0.39	0.71	0.8	0.98	-0.45	-0.75	0.92	0.56	-0.17	0.99	-0.58	0.99	0.83	0.73	0.93	-0.17
Net Debt	-0.99	-0.98		0.51	-0.51	-0.73	-0.88	-0.99	0.38	0.7	-0.89	-0.48	0.12	-0.97	0.54	-0.99	-0.79	-0.67	-0.89	0.12
Retained Earnings	-0.58	-0.55	0.51		-0.49	-0.82	-0.49	-0.55	0.77	0.86	-0.78	-0.9	0.71	-0.53	0.85	-0.59	-0.89	-0.88	-0.77	0.71
Accounts Payable	0.53	0.39	-0.51	-0.49		0.67	0.83	0.52	-0.23	-0.3	0.33	0.44	0.11	0.34	-0.56	0.49	0.53	0.35	0.37	0.11
Net Receivables	0.76	0.71	-0.73	-0.82	0.67		0.74	0.74	-0.65	-0.78	0.78	0.77	-0.35	0.65	-0.72	0.75	0.9	0.75	0.81	-0.35
Total Liab	0.89	0.8	-0.88	-0.49	0.83	0.74		0.89	-0.27	-0.54	0.68	0.46	0.08	0.78	-0.57	0.86	0.71	0.56	0.71	0.08
Total Current Assets	1.0	0.98	-0.99	-0.55	0.52	0.74	0.89		-0.42	-0.71	0.89	0.54	-0.13	0.97	-0.61	1.0	0.82	0.71	0.9	-0.13
Short Term Debt	-0.43	-0.45	0.38	0.77	-0.23	-0.65	-0.27	-0.42		0.58	-0.61	-0.84	0.56	-0.43	0.83	-0.46	-0.73	-0.67	-0.58	0.56
Intangible Assets	-0.74	-0.75	0.7	0.86	-0.3	-0.78	-0.54	-0.71	0.58		-0.91	-0.71	0.65	-0.73	0.62	-0.75	-0.89	-0.95	-0.92	0.65
Net Tangible Assets	0.91	0.92	-0.89	-0.78	0.33	0.78	0.68	0.89	-0.61	-0.91		0.7	-0.53	0.92	-0.68	0.93	0.91	0.87	0.98	-0.53
Long Term Debt	0.56	0.56	-0.48	-0.9	0.44	0.77	0.46	0.54	-0.84	-0.71	0.7		-0.48	0.54	-0.94	0.57	0.9	0.78	0.72	-0.48
Deferred Long Term Liab	-0.15	-0.17	0.12	0.71	0.11	-0.35	0.08	-0.13	0.56	0.65	-0.53	-0.48		-0.21	0.41	-0.2	-0.44	-0.61	-0.44	1.0
Net Invested Capital	0.97	0.99	-0.97	-0.53	0.34	0.65	0.78	0.97	-0.43	-0.73	0.92	0.54	-0.21		-0.58	0.98	0.81	0.71	0.92	-0.21
Short Long Term Debt	-0.62	-0.58	0.54	0.85	-0.56	-0.72	-0.57	-0.61	0.83	0.62	-0.68	-0.94	0.41	-0.58		-0.63	-0.86	-0.76	-0.67	0.41
Net Working Capital	1.0	0.99	-0.99	-0.59	0.49	0.75	0.86	1.0	-0.46	-0.75	0.93	0.57	-0.2	0.98	-0.63		0.85	0.75	0.93	-0.2
Common Stock	0.84	0.83	-0.79	-0.89	0.53	0.9	0.71	0.82	-0.73	-0.89	0.91	0.9	-0.44	0.81	-0.86	0.85		0.9	0.94	-0.44
Property Plant Equipment	0.73	0.73	-0.67	-0.88	0.35	0.75	0.56	0.71	-0.67	-0.95	0.87	0.78	-0.61	0.71	-0.76	0.75	0.9		0.88	-0.61
Capital Stock	0.92	0.93	-0.89	-0.77	0.37	0.81	0.71	0.9	-0.58	-0.92	0.98	0.72	-0.44	0.92	-0.67	0.93	0.94	0.88		-0.44
Current Deferred Revenue	-0.15	-0.17	0.12	0.71	0.11	-0.35	0.08	-0.13	0.56	0.65	-0.53	-0.48	1.0	-0.21	0.41	-0.2	-0.44	-0.61	-0.44

Click cells to compare fundamentals

About XORTX Therapeutics Financial Statements

XORTX Therapeutics investors use historical fundamental indicators, such as XORTX Therapeutics' Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in XORTX Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Debt Ratio	0.05	0.05
Cash Flow To Debt Ratio	(5.65)	(5.93)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

XORTX Debt Ratio from 2010 to 2024

Latest XORTX Therapeutics' Debt Ratio Growth Pattern

XORTX Debt Ratio Regression Statistics

XORTX Debt Ratio History

Other Fundumenentals of XORTX Therapeutics

XORTX Therapeutics Debt Ratio component correlations

About XORTX Therapeutics Financial Statements

Also Currently Popular

Additional Tools for XORTX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY